我們的宗旨，是改善現有的癌症篩檢及預防的方式；我們的目標，是藉由簡單又準確的血液檢測，診斷出早期癌症，以降低其死亡率。
這項獨特的技術是由中央研究院所研發完成，並技術轉移到本公司。本公司除了與中央研究院有專屬的技術合作關係，並由美國矽谷的風險投資公司及台灣業界提供贊助資金。
這項獨特的技術是由中央研究院所研發完成，並技術轉移到本公司。本公司除了與中央研究院有專屬的技術合作關係，並由美國矽谷的風險投資公司及台灣業界提供贊助資金。
Location: United States, California, Sunnyvale
Employees: 51-200
Phone: 0800-555-885
Total raised: $9M
Founded date: 2013
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.07.2016 | Series A | $9M | - |
Mentions in press and media 8
| Date | Title | Description |
| 02.08.2023 | CellMax Life Appoints Dr. Ross D. “Rusty” Segan to Advisory Board | Dr. Ross D. “Rusty” Segan "The FirstSight blood test has repeatedly demonstrated the ability to detect advanced adenomas and CRC with high sensitivity and has the potential to eradicate colon cancer.” - Dr. Ross D. Segan SUNNYVALE, Cal... |
| 06.04.2023 | CellMax Life Announces Expansion of Company Board With Leading Industry Experts | CellMax Life: Stanley Lapidus (L) and Ronnie Andrews (R) SUNNYVALE, Calif. (PRWEB) April 06, 2023 CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood test, today announced the appointment of St... |
| 21.02.2023 | CellMax Life Announces Expansion of GI Medical Advisory Board | SUNNYVALE, Calif. (PRWEB) February 21, 2023 CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood test, today announced the expansion of its medical advisory board. The board is comprised of high... |
| 18.01.2023 | CellMax Life Announces Positive Results From Prospective Multisite Study of Novel Blood Test to Detect Colorectal Cancer and Pre-Cancer | The results from this study are incredibly promising, showing significant potential for this test for colorectal non-invasive cancer screening, thereby increasing our ability to prevent more cancers - Shai Friedland, MD, Stanford Medicine S... |
| 26.07.2018 | CellMax Life receives six patents for early-stage cancer detection test | The product is designed for a purpose similar to Grail, which is also developing a test for early detection of cancers. However, Padma Sundar, CellMax Life’s vice president of marketing, said in a phone interview that what distinguishes her... |
| 26.07.2016 | CellMax Life Secures $9M Series A-1 Round | SUNNYVALE, CA, CellMax Life today announced $9M in series A-1 venture funding. >> Click here for more funding data on CellMax Life >> To export CellMax Life funding data to PDF and Excel, click here CellMax Life today ann... |
| 26.07.2016 | Precision Cancer Blood-Testing Company CellMax Life Raises $9M in Venture Capital | CellMax Life, a Sunnyvale, CA-based precision cancer blood-testing company, raised $9M in series A-1 venture capital funding. The round was led by Artiman and Taiwanese venture capital investors including Stan Shih, founder, and honorable c... |
| - | CellMax Life receives six patents for early-stage cancer detection test | A company in northern California developing a test for the early detection of colorectal cancer has received six patents for its product. Sunnyvale, California-based CellMax Life said Tuesday it was granted the patents for its CMx biomimeti... |